These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2847799)

  • 1. Relationship between sensitivity to 4'-(9-acridinylamino)methanesulfon-m-anisidide and DNA topoisomerase II in a cold-sensitive cell-cycle mutant of a murine mastocytoma cell line.
    Schneider E; Hutchins AM; Darkin SJ; Lawson PA; Ralph RK
    Biochim Biophys Acta; 1988 Nov; 951(1):85-97. PubMed ID: 2847799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of protein synthesis reduces the cytotoxicity of 4'-(9-acridinylamino)methanesulfon-m-anisidide without affecting DNA breakage and DNA topoisomerase II in a murine mastocytoma cell line.
    Schneider E; Lawson PA; Ralph RK
    Biochem Pharmacol; 1989 Jan; 38(2):263-9. PubMed ID: 2464346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 1-beta-D-arabinofuranosylcytosine (ara-C) on nuclear topoisomerase II activity and on the DNA cleavage and cytotoxicity produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and etoposide in m-AMSA-sensitive and -resistant human leukemia cells.
    Bakic M; Chan D; Andersson BS; Beran M; Silberman L; Estey E; Ricketts L; Zwelling LA
    Biochem Pharmacol; 1987 Dec; 36(23):4067-77. PubMed ID: 2825713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of topoisomerase II by murine mastocytoma cells.
    Collett AG; Ralph RK
    Biochim Biophys Acta; 1992 Oct; 1132(3):259-64. PubMed ID: 1329975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of DNA topoisomerase II in the selective resistance of a mammalian cell mutant to DNA minor groove ligands: ligand-induced DNA-protein crosslinking and responses to topoisomerase poisons.
    Smith PJ; Bell SM; Dee A; Sykes H
    Carcinogenesis; 1990 Apr; 11(4):659-65. PubMed ID: 2157558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced DNA break formation and cytotoxicity of the topoisomerase II drug 4'-(9'-acridinylamino)methanesulfon-m-anisidide when combined with hyperthermia in human and rodent cell lines.
    Kampinga HH; van den Kruk G; Konings AW
    Cancer Res; 1989 Apr; 49(7):1712-7. PubMed ID: 2538233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of resistance of non-cycling mammalian cells to 4'-[9-acridinylamino]methanesulphon-m-anisidide: role of DNA topoisomerase II in log- and plateau-phase CHO cells.
    Schneider E; Darkin SJ; Robbie MA; Wilson WR; Ralph RK
    Biochim Biophys Acta; 1988 Mar; 949(3):264-72. PubMed ID: 2831986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsomal activation and increased production of 4'-(9-acridinylamino)-3-methanesulfon-m-anisidide (m-AMSA)-dependent, topoisomerase-associated DNA lesions in nuclei from human HL-60 leukemia cells.
    Gorsky LD; Morin MJ
    Biochem Pharmacol; 1990 May; 39(9):1481-4. PubMed ID: 2159306
    [No Abstract]   [Full Text] [Related]  

  • 9. The interaction between nuclear topoisomerase II activity from human leukemia cells, exogenous DNA, and 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) or 4-(4,6-O-ethylidene-beta-D-glucopyranoside) (VP-16) indicates the sensitivity of the cells to the drugs.
    Estey EH; Silberman L; Beran M; Andersson BS; Zwelling LA
    Biochem Biophys Res Commun; 1987 Apr; 144(2):787-93. PubMed ID: 3034264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of polyamine depletion by alpha-difluoromethylornithine or (2R,5R)-6-heptyne-2,5-diamine on drug-induced topoisomerase II-mediated DNA cleavage and cytotoxicity in human and murine leukemia cells.
    Bakic M; Chan D; Freireich EJ; Marton LJ; Zwelling LA
    Cancer Res; 1987 Dec; 47(24 Pt 1):6437-43. PubMed ID: 2824033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topoisomerase II-mediated DNA damage produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide and related acridines in L1210 cells and isolated nuclei: relation to cytotoxicity.
    Covey JM; Kohn KW; Kerrigan D; Tilchen EJ; Pommier Y
    Cancer Res; 1988 Feb; 48(4):860-5. PubMed ID: 2827887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cisplatin-resistant murine leukemia cell line exhibits increased topoisomerase II activity.
    Barret JM; Calsou P; Larsen AK; Salles B
    Mol Pharmacol; 1994 Sep; 46(3):431-6. PubMed ID: 7935322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of resistance of noncycling mammalian cells to 4'-(9-acridinylamino)methanesulfon-m-anisidide: comparison of uptake, metabolism, and DNA breakage in log- and plateau-phase Chinese hamster fibroblast cell cultures.
    Robbie MA; Baguley BC; Denny WA; Gavin JB; Wilson WR
    Cancer Res; 1988 Jan; 48(2):310-9. PubMed ID: 2825971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topoisomerase II-mediated DNA breaks and cytotoxicity in relation to cell proliferation and the cell cycle in NIH 3T3 fibroblasts and L1210 leukemia cells.
    Markovits J; Pommier Y; Kerrigan D; Covey JM; Tilchen EJ; Kohn KW
    Cancer Res; 1987 Apr; 47(8):2050-5. PubMed ID: 3030540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
    de Jong S; Kooistra AJ; de Vries EG; Mulder NH; Zijlstra JG
    Cancer Res; 1993 Mar; 53(5):1064-71. PubMed ID: 8382551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phorbol ester effects on topoisomerase II activity and gene expression in HL-60 human leukemia cells with different proclivities toward monocytoid differentiation.
    Zwelling LA; Hinds M; Chan D; Altschuler E; Mayes J; Zipf TF
    Cancer Res; 1990 Nov; 50(22):7116-22. PubMed ID: 2171756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilization of the topoisomerase II-DNA cleavage complex by antineoplastic drugs: inhibition of enzyme-mediated DNA religation by 4'-(9-acridinylamino)methanesulfon-m-anisidide.
    Robinson MJ; Osheroff N
    Biochemistry; 1990 Mar; 29(10):2511-5. PubMed ID: 2159323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that a protein kinase enhances amsacrine mediated formation of topoisomerase II-DNA complexes in murine mastocytoma cell nuclei.
    Darkin-Rattray SJ; Ralph RK
    Biochim Biophys Acta; 1991 Feb; 1088(2):285-91. PubMed ID: 1848107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of phorbol ester treatment on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells.
    Zwelling LA; Chan D; Hinds M; Mayes J; Silberman LE; Blick M
    Cancer Res; 1988 Dec; 48(23):6625-33. PubMed ID: 2846155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term inhibition of DNA synthesis and the persistence of trapped topoisomerase II complexes in determining the toxicity of the antitumor DNA intercalators mAMSA and mitoxantrone.
    Fox ME; Smith PJ
    Cancer Res; 1990 Sep; 50(18):5813-8. PubMed ID: 2168281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.